Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Subcutaneous tranexamic acid for bleeding control in rhinoplasty
IRCT20160307026950N78Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Feb 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of tranexamic acid in intraoperative bleeding (2 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoints: Systolic blood pressure, Diastolic blood pressure and 2 more. Started Feb 2026; status: completed.
02
Drugs
tranexamic acid
03
Conditions
intraoperative bleeding
Beyond the preview
Go deeper on IRCT20160307026950N78.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20160307026950N78.